Upper Aerodigestive Tract CancerDEREDIANCT01647477
Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer
A study testing interview and questionnaires in people with Upper Aerodigestive Tract Cancer, run by Centre Oscar Lambret at 6 sites in France.
Trial summary
This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Upper Aerodigestive Tract Cancer
- What is being tested?
- interview and questionnaires
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 6 sitesFrance
- Study dates
- Dec 2012to Feb 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- age ≥ 18 years
- oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
- non treated cancer
- patient informed of his diagnosis
- speak fluent french
- patient covered by health insurance
Show all 9Show fewer
- signed informed consent
- no speech troubles
- patient consents being recorded
Who cannot join
- history of cancer
- psychological history
- patient under guardianship
Trial locations and contacts
6 sites in 1 country.
6 sites in 1 country
France6 sites
Centre Hospitalier
Boulogne-sur-Mer, 62 231
Oscar Lambret Center
Lille, 59 020
Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
Lille, 59 037
La Louviere Hospital
Lille, 59 042
Gray Center
Maubeuge, 59 600
Centre Médical Spécialisé du Littoral
Saint-Martin-Boulogne, 62280
About this study
Official title: Determinants of the Consultation Delay in Cancers of the Upper Aero Digestive Tract
This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult
Read the detailed description
identify wich sociocognitive factors influence the delay to go to a doctor after the emergence of first symptoms
- Conditions
- Upper Aerodigestive Tract Cancer
- Being tested
- interview, questionnaires
- Keywords
- non treated cancer, oral cavity, oropharynx, hypopharynx, larynx, first consultation
- Medical subject headings
- Laryngeal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
interviewBehavioural
25 minutes of semi directive interview
questionnairesBehavioural
questionnaires to answer at baseline 45 minutes
| Study group | Role | What they receive |
|---|---|---|
| questionnaires | Active comparator | 4 questionnaires to answer at baseline 45 minutes approx. Receives: Behavioral: questionnaires |
| interview | Experimental | semi directive interview 105 patients Receives: Behavioral: interview; Behavioral: questionnaires |
What is being measured
The primary outcome is the main question the study is designed to answer.
time of first consultation
median time between date of symptoms appearance and date of first consultation
Measured: baseline
Secondary outcomes (1)
identify variables associated with time of consultation
medical data : medical history, symptoms, entry into care pathway sociodemographic and emotional indicators
Measured: baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2012 (estimated)
- Study startDec 2012
- Primary completionOct 2014
- Study completionFeb 2017
Why it stopped: lack of enrollment
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Upper Aerodigestive Tract CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Oscar Lambret
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Veronique CHRISTOPHE, MDPhD, Study director, Lille 3 University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01647477
- Sponsor's protocol ID
- DEREDIA - 1110
- Other IDs
- 2012-A00005-38
- Acronym
- DEREDIA
- Status last verified
- Mar 2026
- First submitted
- 19 Jul 2012
- Last updated
- 13 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determinants of the Consultation Delay in Cancers of the Upper Aero Digestive Tract
- ClinicalTrials.gov ID
- NCT01647477
- Acronym / sponsor ID
- DEREDIA / DEREDIA - 1110
- Conditions
- Upper Aerodigestive Tract Cancer
- Keywords
- non treated cancer, oral cavity, oropharynx, hypopharynx, larynx, first consultation
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: lack of enrollment
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Centre Oscar LambretUniversity, hospital or other
- Study start
- Dec 2012 (actual)
- Primary completion
- Oct 2014 (actual)
- Study completion
- Feb 2017 (actual)
- First posted
- 23 Jul 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult
Detailed description
identify wich sociocognitive factors influence the delay to go to a doctor after the emergence of first symptoms
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| questionnaires | Active comparator | Behavioral: questionnaires4 questionnaires to answer at baseline 45 minutes approx. |
| interview | Experimental | Behavioral: interview, Behavioral: questionnairessemi directive interview 105 patients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- age ≥ 18 years
- oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
- non treated cancer
- patient informed of his diagnosis
- speak fluent french
Key exclusion criteria (3 listed)
- history of cancer
- psychological history
- patient under guardianship
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| interview25 minutes of semi directive interview | Behavioural | interview |
| questionnairesquestionnaires to answer at baseline 45 minutes | Behavioural | interview, questionnaires |
Primary outcome
time of first consultation
Time frame: baseline
median time between date of symptoms appearance and date of first consultation
1 secondary outcome
identify variables associated with time of consultation
Time frame: baseline
Results and safety
The study was stopped early (reason given: lack of enrollment). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Upper Aerodigestive Tract Cancer
Active, not recruitingPhase 2
Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC
Head and Neck Squamous Cell Carcinoma
RecruitingObservational study
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Head and Neck Cancer, Lung Cancer
Active, not recruitingPhase 2
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Active, not recruitingObservational study
Integrated Molecular Profiling in Advanced Cancers Trial
Breast Cancer, Non-small Cell Lung Cancer
Recruiting
Evolution of Masticatory Function, Orofacial Functions and Quality of Life of Patients Treated for Cancers of the Upper Aerodigestive Tract, Rehabilitated by Maxillofacial Prostheses.
Head and Neck Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Veronique CHRISTOPHE, MDPhD study director
Lille 3 University
6 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing interview and questionnaires in people with Upper Aerodigestive Tract Cancer, run by Centre Oscar Lambret at 6 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: lack of enrollment). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
time of first consultation (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.